Clover Says SEC Started a Probe in Wake of Hindenburg Report
- Company says DOJ’s request for information wasn’t material
- Hindenburg accused health insurer of misleading investors
This article is for subscribers only.
Clover Health Investments Corp. said the Securities and Exchange Commission has started a probe after a research report accused the health-insurance company of misleading investors when it went public.
“Clover received notice of an investigation from the SEC,” the company said in a regulatory filing Friday. “We believe this inquiry is based on the short-selling report issued yesterday morning.”